Good Laboratory Practice
Maxxam adheres to requirements set by the U.S. Food and Drug Administration (FDA)’s Good Laboratory Practice (GLP), as well as Health Canada and the FDA’s Good Manufacturing Practices (GMP). Maxxam is certified by the Standards Council of Canada (SCC) as an Organization for Economic Co-operation and Development (OECD) GLP facility for specific areas of expertise.
According to the decision of the OECD Council Acts on Mutual Acceptance of Data (MAD), GLP compliant studies performed at Maxxam are acceptable in all OECD member countries including the US and the European Union.
Regulatory data is reviewed by technical staff as well as independent quality control and quality assurance auditors. Maxxam GLP/GMP facilities have been FDA inspected; Health Canada GMP licensed and continues to be inspected on an ongoing basis. Maxxam’s GLP Quality Assurance Unit has extensive experience in auditing and monitoring technical conduct in the GLP laboratory and field studies. Our QA team includes several certified GLP quality assurance professionals.
